Megapro Biomedical Co., Ltd.

Taiwan Semiconductor Manufacturing Comp. Ltd.

Wen-Yuan Hsieh

Shian-Jy Jassy Wang

Yuan-Hung Hsu

Chih-Lung Chen

Ming-Cheng Wei

Chia-Wen Huang

Jhih-Yun Jian

Cheng-Yuan Tsai

Yao-Wen Chang

Han-Chin Chiu

Ming-Wei Tsai

Su-Yo Lin

Chen-Hsuan Lin

Shin-Yi Huang

Hsin Jung Huang

A biocompatible magnetic material containing an iron oxide nanoparticle and one or more biocompatible polymers, each having formula (I) below, covalently bonded to the iron oxide nanoparticle: in which each of variables R, L, x, and y is defined herein, the biocompatible magnetic material contains 4-15% Fe(II) ions relative to the total iron ions. Also disclosed in a method of preparing the biocompatible magnetic material.

Biocompatible magnetic materials

A pharmaceutical composition containing a mixed polymeric micelle and a drug enclosed in the micelle, in which the mixed polymeric micelle, 1 to 1000 nm in size, includes an amphiphilic block copolymer and a lipopolymer. Also disclosed are preparation of the pharmaceutical composition and use thereof for treating cancer.

Pharmaceutical compositions containing mixed polymeric micelles

The present disclosure relates to a structure and method of forming a low damage passivation layer for III-V HEMT devices. In some embodiments, the structure has a bulk buffer layer disposed over a substrate and a device layer of III-V material disposed over the bulk buffer layer. A source region, a drain region and a gate region are disposed above the device layer. The gate region comprises a gate electrode overlying a gate separation layer. A bulk passivation layer is arranged over the device layer, and an interfacial layer of III-V material is disposed between the bulk passivation layer and the device layer in such a way that the source region, the drain region and the gate region extend through the bulk passivation layer and the interfacial layer, to abut the device layer.

Low damage passivation layer for III-V based devices

A method of treating a condition related to iron deficiency. The method includes steps of identifying a patient having a condition related to iron deficiency and administering an effective amount of biocompatible iron oxide nanoparticles to the patient. The biocompatible iron oxide nanoparticles each contains an iron oxide core that is covered by one or more biocompatible polymers, each of which has a polyethylene glycol group, a silane group, and a linker linking, via a covalent bond, the polyethylene glycol group and the silane group.

Method of treating iron deficiency

Growing community of inventors

Hsinchu, Taiwan

Wen-Yuan Hsieh